Follow
Alexis Hammond, MD PhD
Alexis Hammond, MD PhD
Johns Hopkins University, Department of Psychiatry and Behavioral Sciences
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone
DJ Toufexis, C Davis, A Hammond, M Davis
Journal of Neuroscience 24 (45), 10280-10287, 2004
1022004
Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology
AS Hammond, AL Rodriguez, SD Townsend, CM Niswender, KJ Gregory, ...
ACS chemical neuroscience 1 (10), 702-716, 2010
812010
Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone
D Antoine, AS Huhn, EC Strain, G Turner, J Jardot, AS Hammond, ...
The American Journal on Addictions 30 (1), 83-87, 2021
722021
Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male
D Toufexis, C Davis, A Hammond, M Davis
Journal of Neuroscience 25 (39), 9010-9016, 2005
592005
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement
KJ Gregory, EJ Herman, AJ Ramsey, AS Hammond, NE Byun, SR Stauffer, ...
Journal of Pharmacology and Experimental Therapeutics 347 (2), 438-457, 2013
522013
Synthesis, SAR and Unanticipated Pharmacological Profiles of Analogues of the mGluR5 Ago‐potentiator ADX‐47273
DW Engers, AL Rodriguez, R Williams, AS Hammond, D Venable, ...
ChemMedChem: Chemistry Enabling Drug Discovery 4 (4), 505-511, 2009
432009
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health
AS Hammond, MM Sweeney, TU Chikosi, ML Stitzer
Journal of substance abuse treatment 126, 108425, 2021
342021
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper
AS Huhn, PH Finan, CE Gamaldo, AS Hammond, A Umbricht, ...
Science translational medicine 14 (650), eabn8238, 2022
292022
Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the …
M Stitzer, T Matheson, C Cunningham, JL Sorensen, DJ Feaster, ...
Addiction Science & Clinical Practice 12, 1-6, 2017
252017
The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone
AS Huhn, RK Brooner, MM Sweeney, D Antoine, AS Hammond, H Ayaz, ...
Addictive behaviors 113, 106673, 2021
152021
Enhancing patient navigation with contingent incentives to improve healthcare behaviors and viral load suppression of persons with HIV and substance use
ML Stitzer, AS Hammond, T Matheson, JL Sorensen, DJ Feaster, R Duan, ...
AIDS patient care and STDs 32 (7), 288-296, 2018
152018
Drug legalization and decriminalization beliefs among substance-using and nonusing individuals
AS Hammond, KE Dunn, EC Strain
Journal of addiction medicine 14 (1), 56-62, 2020
92020
TBPB is a highly selective M1 allosteric mscarinic receptor agonist in vitro and produces robust antipsychotic-like effects in vivo
CK Jones, AE Brady, M Bubser, AY Deutch, LC Williams, AS Hammond, ...
Neuropsychopharmacology 31, S116-S117, 2006
92006
A randomized and controlled acceptability trial of an internet-based therapy among inpatients with co-occurring substance use and other psychiatric disorders
AS Hammond, DG Antoine, ML Stitzer, EC Strain
Journal of Dual Diagnosis 16 (4), 447-454, 2020
72020
Perceived attitudes about substance use in anonymous social media posts near college campuses: Observational study
AS Hammond, MJ Paul, J Hobelmann, AR Koratana, M Dredze, ...
JMIR Mental Health 5 (3), e9903, 2018
52018
Drug-free community support in inpatients with co-occurring psychiatric disorders and substance use problems
A Hammond, M Batkis, P Rostov, H Yan, M Kidorf
Journal of dual diagnosis 18 (4), 177-184, 2022
22022
Patient attitudes toward technology-assisted treatment during hospital-based dual-diagnosis treatment
AS Hammond, EC Strain, J Hsu, DG Antoine
Drug and Alcohol Dependence 100 (156), e88, 2015
12015
Novel allosteric modulators of metabotropic glutamate receptors subtypes 2 and 5 for the treatment of schizophrenia
CK Jones, F Xiang, A Jones, NE Byun, EA Hackler, AL Rodriguez, ...
Neuropharmacology 55, 603-603, 2008
12008
The Impact of Child Protective Services Involvement on Pregnant and Postpartum Women in Substance Use Disorder Treatment
D Colson-Fearon, DG Antoine, JM Peirce, M Kidorf, AS Hammond
Substance Use & Misuse 58 (9), 1110-1114, 2023
2023
Psychosocial Treatment Methods
JM Peirce, DG Antoine, AS Hammond, MS Kidorf
2023
The system can't perform the operation now. Try again later.
Articles 1–20